To investigate whether the ameliorative effect of TMEM176B on pulmonary fibrosis operates via the TGF-β-SMAD2/3 signaling, we utilized SB431542, an inhibitor of TGF-β. The gene discussed is SMAD2; the disease is pulmonary fibrosis.